GSK stops development of chronic cough drug after late-stage trial miss - Reuters
GSK stops development of chronic cough drug after late-stage trial miss Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxOOTJyXzZma0ZYNnRvRjM1c0kzLWg1eEVWSXdkNVRHTlFZR29CMzFReWlicTZiX0ZUOEdzbTB0UmM4VmlRMTdieHNHT2I5RjJPWHR3X0swbF9Ua0xLTXVfdmVCWDM4aE5mRkJHWTM3d1JOcjFxLWJsQjFVdHQtRHF0dTRud3Z4cXlyR25ZVWhkN2lGTEZrUVJJQ0FCZ0Q4SDU5SE1HcE1NTUdzaUtsQm1aWm5tVFA2SlNKU3hfSWw5R2N0SWlKSDQ0eVBxeTBMTXA3?oc=5" target="_blank">GSK stops development of chronic cough drug after late-stage trial miss</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Argenx discontinues Vyvgart study in Sjögren's disease, shares tumble - Reuters
Argenx discontinues Vyvgart study in Sjögren's disease, shares tumble Reuters
October 8, 2026 at 08:49 PMViatris bets on non-opioid pain drugs with $1.65 billion Pacira deal - Reuters
Viatris bets on non-opioid pain drugs with $1.65 billion Pacira deal Reuters
October 8, 2026 at 02:39 PMCSL strikes rare disease drug deal worth up to $1.6 billion with Swiss firm Alentis - Reuters
CSL strikes rare disease drug deal worth up to $1.6 billion with Swiss firm Alentis Reuters
October 4, 2026 at 10:18 PMAbbVie joins US government pilot to test drug discount rebates - Reuters
AbbVie joins US government pilot to test drug discount rebates Reuters
October 2, 2026 at 08:53 PMBayer to invest $2.2 billion in new US pharma site - Reuters
Bayer to invest $2.2 billion in new US pharma site Reuters
October 2, 2026 at 07:19 PMSanofi to pay Regeneron $1 billion upfront in expanded immunology deal - Reuters
Sanofi to pay Regeneron $1 billion upfront in expanded immunology deal Reuters
October 1, 2026 at 05:17 AM